Drugs / Hookworm larvae
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01470521 | Dec 2011 → Jan 2016 | relapsing-remitting multiple sclerosis | University of Nottingham | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hookworm larvae | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01470521 ↗ |
| Modality | Other / unclassified | “It appears that a living organism can precipitate immunoregulatory changes that may affect MS disease activity.” PMID 32539079 ↗ Sep 2020 |
| Route | Other | “Patients were randomized (1:1) to receive either 25 Necator americanus larvae transcutaneously or placebo.” PMID 32539079 ↗ Sep 2020 |